← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2006
SPARC— Founded
2010s
- Dec 20, 2018
levetiracetam— NDA Secondary Org
2020s
- Nov 17, 2022
phenobarbital— Marketing Organization
Drugs by trial phase (24 distinct, 33 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Back Pain
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Conjunctivitis
- Conjunctivitis, Allergic
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glaucoma
- Glaucoma, Open-Angle
- Hypertension
- Inflammation
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lewy Body Disease
- Low Back Pain
- Multiple Myeloma
- Muscle Spasticity
- Myalgia
- Neoplasms, Plasma Cell
- Ocular Hypertension
- Ovarian Neoplasms
- Parkinson Disease
- Recurrence
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
Marketed drugs (2)
Recent trials (35)
- NCT04332549Lead sponsorPhase 1Apr 27, 2020
- NCT04242953Lead sponsorPhase 1Feb 29, 2020
- NCT03996460CollaboratorPhase 2Jul 31, 2019
- NCT03655236Lead sponsorPhase 2Oct 31, 2018
- NCT03450629Lead sponsorPhase 3Aug 31, 2018
- NCT03426267Lead sponsorPhase 3Aug 30, 2018
- NCT03445338Lead sponsorPhase 1Apr 15, 2018
- NCT03567941Lead sponsorPhase 1Dec 29, 2017
- NCT03109249Lead sponsorPhase 1Jul 15, 2017
- NCT02991261Lead sponsorPhase 1Feb 21, 2017
- NCT03316820Lead sponsorPhase 1Jan 22, 2017
- NCT02991222Lead sponsorPhase 1Jan 1, 2017
- NCT02970019Lead sponsorPhase 2Jan 1, 2017
- NCT02597465Lead sponsorPhase 3Dec 1, 2016
- NCT02887534Lead sponsorPhase 2Nov 1, 2016
Details
- Founded
- Mumbai, IN Jun 1, 2006
- Last known activity
- Apr 27, 2020